Galena biopharma stock

Prev Close 68.25, 52 Wk Low 47.58. Open 69.80, 52 Wk High 71.15. Day Low 68.30, Volume 140,403.00. Day High 70.25, Avg 10D Vol - 

Stock split history for Galena Biopharma since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. GALENA BIOPHARMA INC : Stock Price | MarketScreener SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical Stocks to Watch: Anthera Pharma, Galena Biopharma, Delta Air Dec 28, 2016 · Among the companies with shares expected to trade actively in Wednesday's session are Anthera Pharmaceuticals Inc., Galena Biopharma Inc. and Delta Air Lines Inc. Galena Biopharma (GALE) Stock Message Board - InvestorsHub

May 10 2017, Galena Biopharma Reports First Quarter 2017 Financial Results July 28 2016, Aytu BioScience, Inc. Announces Common Stock Purchase 

Mar 02, 2020 · Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio … Galena Biopharma Inc. - NASDAQ:GALE - Stock Quote & News ... View detailed financial information, real-time news, videos, quotes and analysis on Galena Biopharma Inc. (NASDAQ:GALE). Explore commentary on Galena Biopharma Inc. and hear what the experts at Galena Biopharma | Crunchbase Aug 14, 2017 · Galena Biopharma, Inc. (Galena) is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet … GALE - Galena Biopharma In Stock Profile - Barchart.com

News Details - Sellas Life Sciences

Galena Biopharma: Class Action — Stock Fraud News ...

Why Galena Biopharma, Inc. Stock Crashed By 52% in 2014 ...

Mar 08, 2017 · The description continues: “Galena’s pipeline consists of multiple mid-to-late-stage clinical assets led by its hematology asset, GALE-401, and its novel cancer immunotherapy programs including NeuVax™ (nelipepimut-S) and GALE-301/GALE-302.” A class action lawsuit has already been filed in connection with Galena Biopharma. Galena Biopharma Inc. to Pay More Than $7.55 Million to ... Sep 08, 2017 · Galena Biopharma Inc. (Galena) will pay more than $7.55 million to resolve allegations under the civil False Claims Act that it paid kickbacks to doctors to induce them to prescribe its fentanyl-based drug Abstral, the Department of Justice announced today. Requested symbol wasn't found - Business Finance, Stock ...

Dec 29, 2017 · Canaccord Genuity Inc. acted as Galena’s financial advisor for the transaction and Paul Hastings LLP and BeesMont Law Limited acted as Galena’s legal counsel. About the Transaction . In connection with and prior to the closing of the merger, Galena effected a …

Galena Biopharma Pays For Stock-Touting Campaign While ... Feb 12, 2014 · Galena was promoted on many of the DreamTeam stock-touting Web sites to create "market buzz about the company to a new group of investors," according to a DreamTeam document, "Galena Biopharma Galena Biopharma - GALE - Stock Price & News | The Motley Fool Apr 02, 2020 · Primary metrics and data points about Galena Biopharma. Industry, sector and description for Galena Biopharma. Galena Biopharma Inc is a biotechnology company focused on discovering developing and Galena Biopharma stock surges 21% after independent group ...

Aug 9, 2017 in an all-stock transaction. The new company will take on the Sellas' name and list on Nasdaq, with Galena stock and warrant holders expected to  Galena Biopharma, Inc. is focused on discovering, developing and IPO Status Delisted Stock Symbol NASDAQ:GALE Company Type For Profit. Website  Find the latest SELLAS LIFE SCIENCES GROUP INC (GALE) stock quote, history , news and other vital information to help you with your stock trading and  As of February 28, 2017, Galena Biopharma, Inc. had outstanding 35,921,324 shares of common stock, $0.0001 par value per share, exclusive of treasury